Group 1 - The company announced that it will hold its second employee representative assembly on September 19, 2025 [2] - Li Juan has been elected as the employee representative director for the company's ninth board of directors [2]

公司于 2025 年 9 月 19 日召开公司 2025 年第二次职工代表大会，选举李娟 女士（简历附后）为公司第九届董事会职工代表董事，任期自公司职工代表大会 选举通过之日起至公司第九届董事会任期届满之日止。 一、董事辞职情况 近日，因公司治理结构优化需要，华峰化学股份有限公司（以下简称"公司"） 董事、董事会秘书李亿伦女士，申请辞去公司董事职务，辞去上述职务后将继续 担任公司董事会秘书之职。李亿伦女士的辞职不会导致公司董事会成员低于法定 最低人数，不会影响公司董事会正常运行，亦不会对公司正常经营产生不利影响， 其辞职自公司董事会收到辞职报告之日起生效。 截至本公告披露日，李亿伦女士持有公司股份 8,700 股，李亿伦女士将继续 遵守《深圳证券交易所上市公司自律监管指引第 10 号——股份变动管理》等法 律法规相关规定。 李亿伦女士在担任公司董事期间恪尽职守、勤勉尽责，公司及董事会对李亿 伦女士在任职期间所作的辛勤工作和突出贡献表示衷心感谢！ 二、选举职工代表董事的情况 根据《中华人民共和国公司法》《深圳证券交易所股票上市规则》及《公司 章程》等相关规定，公司董事会设职工代表董事一名。 证券代码：00206 ...

Meeting Overview - The second extraordinary general meeting of shareholders for Huafeng Chemical Co., Ltd. was convened by the ninth board of directors on September 18, 2025, at 15:00 in Ruian, Zhejiang Province [2] - The meeting was conducted both in-person and via online voting, with specific time slots allocated for each voting method [2] Attendance and Voting - A total of 411 shareholders participated in the voting, representing 3,572,538,359 shares, which accounts for 71.9901% of the total voting shares [3] - Among these, 8 shareholders voted in person, representing 368,070,512 shares (7.4170%), while 403 shareholders voted online, representing 3,204,467,847 shares (64.5731%) [3] Minority Shareholder Participation - 404 minority shareholders participated, representing 285,124,232 shares, which is 5.7455% of the total voting shares [4] - Of these, 5 minority shareholders voted in person, representing 40,893,200 shares (0.8240%), and 399 voted online, representing 244,231,032 shares (4.9215%) [4] Proposal Review Amendment of Articles of Association - The proposal to amend the Articles of Association was approved with 3,571,075,059 shares in favor (99.9590%), 1,397,300 shares against (0.0391%), and 66,000 shares abstaining (0.0018%) [5] - Minority shareholders voted 283,660,932 shares in favor (99.4868%), 1,397,300 shares against (0.4901%), and 66,000 shares abstaining (0.0231%) [6] Shareholders' Meeting Rules - The proposal to amend the Shareholders' Meeting Rules was approved with 3,522,307,209 shares in favor (98.5940%), 50,137,250 shares against (1.4034%), and 93,900 shares abstaining (0.0026%) [8] - Minority shareholders voted 234,893,082 shares in favor (82.3827%), 50,137,250 shares against (17.5844%), and 93,900 shares abstaining (0.0329%) [10] Board Meeting Rules - The proposal to amend the Board Meeting Rules was approved with 3,522,103,384 shares in favor (98.5883%), 50,323,875 shares against (1.4086%), and 111,100 shares abstaining (0.0031%) [12] - Minority shareholders voted 234,689,257 shares in favor (82.3112%), 50,323,875 shares against (17.6498%), and 111,100 shares abstaining (0.0390%) [13] Independent Director Work System - The proposal for the Independent Director Work System was approved with 3,504,222,600 shares in favor (98.0878%), 50,157,475 shares against (1.4040%), and 18,158,284 shares abstaining (0.5083%) [15] - Minority shareholders voted 216,808,473 shares in favor (76.0400%), 50,157,475 shares against (17.5914%), and 18,158,284 shares abstaining (6.3686%) [16] Related Party Transaction Decision-Making System - The proposal for the Related Party Transaction Decision-Making System was approved with 3,522,238,909 shares in favor (98.5921%), 50,234,350 shares against (1.4061%), and 65,100 shares abstaining (0.0018%) [17] - Minority shareholders voted 234,824,782 shares in favor (82.3588%), 50,234,350 shares against (17.6184%), and 65,100 shares abstaining (0.0228%) [18] External Guarantee System - The proposal for the External Guarantee System was approved with 3,521,372,489 shares in favor (98.5678%), 50,611,270 shares against (1.4167%), and 554,600 shares abstaining (0.0155%) [19] - Minority shareholders voted 233,958,362 shares in favor (82.0549%), 50,611,270 shares against (17.7506%), and 554,600 shares abstaining (0.1945%) [21] 2025 Interim Profit Distribution Plan - The proposal for the 2025 Interim Profit Distribution Plan was approved with 3,571,471,759 shares in favor (99.9701%), 994,200 shares against (0.0278%), and 72,400 shares abstaining (0.0020%) [22] - Minority shareholders voted 284,057,632 shares in favor (99.6259%), 994,200 shares against (0.3487%), and 72,400 shares abstaining (0.0254%) [23] Legal Opinion - The meeting was witnessed by lawyers from Zhejiang Anyang Law Firm, confirming that the meeting's procedures complied with relevant laws and regulations [24] Documents for Reference - The resolutions from the second extraordinary general meeting of shareholders and the legal opinion from Zhejiang Anyang Law Firm are available for review [25]

华峰化学股份有限公司 独立董事工作制度 第一章 总则 第一条 为进一步完善华峰化学股份有限公司（以下简称公司）的法人治理结构， 促进公司的规范运作，改善董事会结构，强化对内部董事及经理层的约束和监督机制， 保护中小股东及利益相关者的利益，根据《中华人民共和国公司法》《中华人民共和国证 券法》《上市公司独立董事管理办法》以及公司章程等相关规定，特制定本制度。 第二条 独立董事是指不在公司担任除董事外的其他职务，并与公司及其主要股东、 实际控制人不存在直接或者间接利害关系，或者其他可能影响其进行独立客观判断关系 的董事。 独立董事对公司及全体股东负有诚信与勤勉义务。独立董事应当按照相关法律法规、 公司章程的要求，认真履行职责，维护公司整体利益，尤其要关注中小股东的合法权益 不受侵害。 第三条 公司聘请独立董事的人数应符合公司章程的规定，独立董事占董事会成员 的比例不得低于三分之一，且至少包括一名会计专业人士。（本条所称会计专业人士系指 具备较丰富的会计专业知识和经验，并至少符合下列条件之一： （一）具有注册会计师资格； （二）具有会计、审计或者财务管理专业的高级职称、副教授及以上职称或者博士 学位； （三）具有经 ...

证券代码：002064 证券简称：华峰化学 公告编号：2025-053 华峰化学股份有限公司 2025年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： （一）审议通过了《关于修订<公司章程>的议案》 1、本次股东大会召开期间无增加、否决或变更提案的情况； 2、本次股东大会以现场结合网络投票的方式召开。 一、会议召开和出席情况 华峰化学股份有限公司2025年第二次临时股东大会由公司第九届董事会召 集并于2025年9月2日发出通知，现场会议于2025年9月18日下午15:00在浙江省瑞 安市经济开发区开发区大道1688号205会议室召开；网络投票时间：2025年9月18 日。其中，通过深圳证券交易所交易系统进行网络投票的时间为2025年9月18日 9:15—9:25、9:30—11:30和13:00—15:00；通过深圳证券交易所互联网投票的具体 时间为2025年9月18日9:15—15:00的任意时间。 会议由公司董事会召集，董事长尤飞煌先生主持，公司部分董事、监事、高 级管理人员出席了本次会议，见证律师等相关人员列席了本 ...

浙江安阳律师事务所 关于华峰化学二〇二五年第二次临时股东大会的法律意见书 浙江安阳律师事务所 关于华峰化学股份有限公司二〇二五年 第二次临时股东大会的法律意见书 致: 华峰化学股份有限公司 根据《中华人民共和国证券法》（以下简称"证券法"） 、《中华人民共和 国公司法》（以下简称"公司法"）和中国证券监督管理委员会《上市公司股东 会规则》（以下简称"股东会规则"）等法律、法规和其他有关规范性文件的要 求，浙江安阳律师事务所（以下简称"本所"）接受华峰化学股份有限公司（以 下简称"华峰化学"或"公司"）的委托，指派本所律师出席华峰化学二〇二五 年第二次临时股东大会，并出具本法律意见书。 本法律意见书仅供华峰化学二〇二五年第二次临时股东大会之目的使用。 本所律师同意将本法律意见书随华峰化学本次股东大会其他信息披露资料一并 公告。 本所律师根据《证券法》、《公司法》及《股东会规则》等法律法规和其他 规范性文件的要求，按照律师行业公认的业务标准、道德规范和勤勉尽责的精神， 对华峰化学本次股东大会所涉及的有关事项和相关文件进行了必要的核查和验 证，出席了华峰化学二〇二五年第二次临时股东大会，现出具法律意见如下。 一、关 ...

Summary of Huafeng Chemical Conference Call Industry Overview - **Industry**: Spandex (Polyurethane Synthetic Fiber) - **Growth Rate**: The compound annual growth rate (CAGR) for spandex from 2017 to 2024 is over 10%, driven by demand for outdoor clothing and leisure sports trends, indicating potential for increased per capita consumption in China [2][7] - **China's Position**: China is the largest producer and consumer of spandex globally, with a production of 890,000 tons in 2023 and only 70,000 tons exported, highlighting a domestic demand-driven market [8] Company Insights - **Company**: Huafeng Chemical - **Production Capacity**: Expected to reach 325,000 tons in 2024 and 400,000 tons in 2025, positioning it as a leader alongside Xiaoxin Group [2][11] - **Sales Performance**: Anticipated spandex sales of 368,000 tons in 2024 with an operating rate close to 110%, significantly above the industry average of 80% [19] - **Financial Health**: Despite a challenging environment, Huafeng is projected to achieve approximately 3 billion yuan in cash flow and 2.3 billion yuan in net profit, with a cash reserve of 5.5 billion yuan [28] Market Dynamics - **Current Market Conditions**: Spandex profitability is near the bottom, with current earnings around 2,000 yuan per ton. A price increase to 40,000-50,000 yuan per ton could yield significant profit increments of 4-8 billion yuan [24] - **Inventory and Pricing**: High inventory levels and declining prices are current challenges, but a recovery in valuation is expected by 2025, with potential profit reversals by 2026 [15][24] Competitive Landscape - **Competitors**: Xiaoxin Group is considering asset sales, which could further solidify Huafeng's market position. Other competitors like Taehwa and Xinyang Chemical are facing significant challenges, with some potentially exiting the market [12][15] - **Market Share**: Huafeng controls over 70% of the heart liquid market, indicating a monopolistic position despite current weak demand [26] Future Outlook - **Growth Potential**: By 2026, Huafeng anticipates an increase in earnings per share (EPS) and overall growth, with potential profits reaching 10 billion yuan if market conditions improve [29] - **Valuation**: The company is currently undervalued at a market cap of 40 billion yuan, with projections suggesting a target market cap of 660 billion yuan by 2025 based on a conservative 20x price-to-earnings ratio [28][29] Additional Insights - **Technological Advancements**: Huafeng has achieved significant scale effects through technological improvements, allowing for lower investment per ton compared to industry averages [22] - **Raw Material and Energy Costs**: Proximity to raw material sources and strong bargaining power have enabled Huafeng to maintain lower costs, enhancing profitability [23] This summary encapsulates the key points from the conference call, highlighting the current state and future potential of Huafeng Chemical within the spandex industry.

Market Overview - On September 17, the chemical fiber sector declined by 0.63%, with Huilong New Materials leading the drop [1] - The Shanghai Composite Index closed at 3876.34, up 0.37%, while the Shenzhen Component Index closed at 13215.46, up 1.16% [1] Stock Performance - Notable gainers in the chemical fiber sector included: - Tongyi Zhong: closed at 20.36, up 3.09% with a trading volume of 117,500 shares and a turnover of 239 million yuan [1] - Wanwei High-tech: closed at 5.98, up 1.36% with a trading volume of 561,900 shares and a turnover of 333 million yuan [1] - Major decliners included: - Huilong New Materials: closed at 26.33, down 5.93% with a trading volume of 39,400 shares and a turnover of 106 million yuan [2] - Shenma Co.: closed at 9.71, down 4.24% with a trading volume of 323,700 shares and a turnover of 318 million yuan [2] Capital Flow - The chemical fiber sector experienced a net outflow of 119 million yuan from institutional investors, while retail investors saw a net inflow of 112 million yuan [2][3] - The capital flow for key stocks showed: - Wanwei High-tech: net inflow of 20.83 million yuan from institutional investors, but a net outflow of 10.29 million yuan from speculative funds [3] - Huilong New Materials: significant net outflow of 18.21 million yuan from speculative funds [3]

Summary of Conference Call Records Industry and Companies Involved - **Companies**: 合盛硅业 (Hesheng Silicon Industry) and 华峰化学 (Huafeng Chemical) - **Industry**: Silicon-based new materials and polyurethane industry Key Points and Arguments Hesheng Silicon Industry - Hesheng Silicon Industry is a leading player in China's silicon-based new materials sector, benefiting from low-cost coal and electricity resources in Xinjiang, which allows for coal-electric-silicon integration to reduce production costs [1] - The company has significant production capacity in industrial silicon and organic silicon, with plans for further expansion in polysilicon, which is expected to benefit from improved photovoltaic industry policies [1] - The industrial silicon market is characterized by price volatility, but global demand is steadily increasing due to the needs of photovoltaic components and organic silicon, alongside export growth from overseas economic recovery [1][6] - Hesheng's industrial silicon capacity is projected to reach 1.87 million tons in 2024, with organic silicon production at full capacity, while polysilicon projects are still under construction [4] Organic Silicon Market - Organic silicon has a wide range of applications, particularly in emerging industries like lithium batteries and photovoltaic components, with a compound annual growth rate (CAGR) of over 10% in recent years [5] - The rapid expansion of domestic organic silicon capacity in the past two years has led to price declines, but limited new capacity and shutdowns of overseas production are expected to optimize supply and drive prices up in the next two years [5] Industrial Silicon Market - Industrial silicon prices have historically fluctuated, with peaks reaching 60,000 yuan per ton and lows below 10,000 yuan in 2025 [6] - Global demand for industrial silicon is projected to grow from 2.44 million tons in 2011 to 5.5 million tons in 2024, with a CAGR of 7.7% [6] - Supply-side constraints, including the elimination of small, inefficient furnaces and a slowdown in new capacity additions, are expected to improve the supply structure and potentially drive prices higher [6] Huafeng Chemical - Huafeng Chemical is the largest producer of spandex in China and a leading global player in adipic acid and shoe sole raw materials, with a production capacity of 325,000 tons of spandex and 1.355 million tons of adipic acid [10] - The spandex market is currently at a historical low, but demand is expected to grow due to increased consumption in sportswear, casual wear, and formal attire, as well as new applications [11] - Adipic acid is widely used in nylon and polyurethane, with a projected consumption of nearly 2 million tons in China by 2024, but current oversupply has led to low prices [12] Cost Advantages of Huafeng Chemical - Huafeng Chemical has significant cost advantages in production processes, energy supply, labor costs, and depreciation, allowing it to maintain lower production costs than competitors by 1,000-3,000 yuan per ton [13] - The company’s profitability is supported by its ability to navigate industry cycles, with a current profit of approximately 2,000 yuan per ton for spandex [13] Future Outlook - Hesheng Silicon Industry is expected to benefit from market changes due to anti-involution policies, with potential improvements in cash flow and profitability as prices for organic silicon and industrial silicon rise [8][9] - Huafeng Chemical's performance is projected to reach around 2 billion yuan by 2025, with a price-to-earnings ratio of about 20 times, indicating potential for growth if market conditions improve [14] Other Important Insights - The market is currently divided on Hesheng's ability to recover and the potential risks related to its high debt levels, with a debt-to-asset ratio of 63% and significant short-term liabilities [7] - The anticipated exit of high-cost competitors from the market may further support price recovery for both spandex and adipic acid [11][12]

Group 1 - Eastman Chemical International GmbH and Huafeng Chemical Co., Ltd. have established a new joint venture [1] - The public notice period for this joint venture is from September 16, 2025, to September 25, 2025 [2]